THE RESULTS OF THE USE OF BIOTECHNOLOGICAL DRUGS IN VETERINARY MEDICINE, PROMISING FOR MEDICINE (PART 1)

Cell and serum nucleases are considered as a natural biological barrier, one of the first links in the body’s antiviral defense: nucleases act on viruses that the usual immunological barrier cannot resist. Inactivation of the enzymatic properties of nucleases also leads to the loss of their antiviral activity. It was found that the nucleases do not inactivate the native virus outside the cell and act mainly on the virus that multiplies in the cells. There is a direct dependence of the antiviral activity of endonuclease on the concentration of the enzyme in the medium. The first antiviral drug created on the basis of the Serratia marcescens endonuclease was called bacterial endonuclease. Its technology was developed by joint research of NIKTI BAS of the Ministry of Medical Industry (Berdsk, Novosibirsk region) and ICIG SB of the USSR Academy of Sciences in 1973–1984. Serratia marcescens endonuclease is capable of cleaving the nucleic acids of both RNA and DNA-containing viruses. The enzyme inhibits the reproduction of vesicular stomatitis and smallpox vaccine viruses in chicken fibroblast cell culture, respectively. It was the first antiviral drug in the history of beekeeping, designed to prevent acute and chronic paralysis and other viral diseases of bees. The drug was also intended as an antiviral agent for a wide range of diseases in various organisms. The effectiveness of bacterial endonuclease as a means of prevention and treatment of respiratory viral diseases in calves was studied. The research was carried out at the industrial complex for growing heifers of the Gosnensky state farm in the Leningrad region on calves of a black-and-white breed of 20–60 days old. For the experiments, we used bacterial endonuclease produced by the Vyshnevolotsky Plant of Enzyme Preparations or NICTI BAS of the Ministry of Medical Industry. In the future, NIKTI BAV together with Diafarm LLC developed a second – generation antiviral drug, endoglucin, based on bacterial endonucleosis. Production experiments to study its effect as a therapeutic and prophylactic agent for respiratory diseases of calves were conducted during 2007– 2011. in the agricultural complex «Prichulymsky» of the Achinsky district of the Krasnoyarsk Territory with the participation of the Department of Epizootology and Parasitology of the Faculty of Veterinary Medicine of KrasGAU and in CJSC «Suzdalskoye» of the Dovolensky district of the Novosibirsk region. Prophylactic use of endoglucin in calves with bronchopneumonia can reduce the incidence from 2.2 to 3.1 times. The drug endoglucin in combination with drugs indicated for the treatment of pulmonary pathology, has therapeutic effectiveness in bronchopneumonia of calves.

1. Alikin Yu.S., Danilenko E.D., Lebedev L.R., Podgornyj V.F., Puti i napravleniya sovershenstvovaniya grazhdanskoj oborony, povysheniya bezopasnosti naseleniya i territorij municipal’nyh obrazovanij sub’ektov Rossijskoj Federacii Sibirskogo federal’nogo okruga (Ways and directions of improving civil defense, improving the security of the population and territories of municipalities of the subjects of the Russian Federation of the Siberian Federal District), Proceedings of the Conference Title, Novosibirsk, 2014, pp. 66–71. (In Russ.)

2. Truhachev A.A., Dejstvie DNK-azy na sintez i razmnozhenie nekotoryh DNK-soderzhashchih virusov (The effect of DNA-aza on the synthesis and reproduction of certain DNA-containing viruses), Extended abstract of candidate’s thesis, Novosibirsk, 1968, 22 p. (In Russ.)

3. Batalina T.A., Izuchenie dejstviya pankreaticheskoj RNK-azy na razmnozhenie nekotoryh RNKsoderzhashchih virusov (Study of the effect of pancreatic RNAASE on the reproduction of certain RNA-containing viruses), Extended abstract of candidate’s thesis, Novosibirsk, 1970, 23 p. (In Russ.)

4. Salganik R.I., Truhachev A.A., Batalina T.A., Ingibitory virusnoj aktivnosti, Riga, 1972, pp. 147–152.

5. Poltev V.I., Talpalackij P.L., Salganik R.I., XXIII Mezhdunarodnyj kongress po pchelovodstvu (XXIII International Congress on Beekeeping), Abstracts of Reports, Moscow, 1971, pp. 77–78. (In Russ.)

6. Lesnikov E.P., Salganik R.I., Svedeniya o terapevticheskoj effektivnosti DNKazy pri nekotoryh zabolevaniyah kozhi i slizistyh, (3rd All-Union Congress of Dermatovenerologists), Abstracts of Papers, Gor’kij, 1971, 129 p. (In Russ.)

7. Gluhov B.M., ZHMEI, 1970, No. 2, pp. 56–58. (In Russ.)

8. Klyueva M.A. Lekarstvennye sredstva, primenyaemye v medicinskoj praktike v SSSR (Medicinal products used in medical practice in the USSR), Moscow: Medicina, 1989, pp. 104, 320–321.

9. Salganik R.I., Zagrebel’nyj S.N., Gracheva S.F., Veterinariya, 1985, No. 5, pp. 42–44. (In Russ.)

10. A.s. № 1422418 SSSR. Sposob bor’by s virusnymi infekciyami nasekomyh (A method for combating insect viral infections), No. 4073281, Priority from 02.06.86; Registered 08.05.88.

11. Batuev Yu.M., Pchelovodstvo, 1992, No. 7–8, pp. 18–19. (In Russ.)

12. Alikin Yu.S., Masycheva V.I., Klimenko V.P., Batuev Yu.M., Grobov O.F., Pchelovodstvo, 1996, No. 4, pp. 17–19. (In Russ.)

13. Pat. No. 2038776 of the Russian Federation dated 05.07.95.

14. Alikin Yu.S., Klimenko V.P., Senzhenko L.P., Ispol’zovanie preparatov na osnove endonukleazy Serracia marcescens protiv respiratornyh boleznej telyat (The use of drugs based on endonuclease Serracia marcescens against respiratory diseases of calves), Abstracts of the 1st Scientific and Practical Conference of the Faculty of Veterinary Medicine of NGAU, Novosibirsk, 1997, pp. 13–14. (In Russ.)/